Cartesian Therapeutics, Inc.
RNAC • NASDAQ • Stock Fundamentals
Cartesian Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carsten Brunn, with a market cap of $236.8M.
Market Cap$236.8M
Employees38.0
CEOCarsten Brunn
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Cartesian Therapeutics, Inc. FAQ
Common questions about Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. (RNAC) has a market capitalization of $236.8M and trades on NASDAQ.
Cartesian Therapeutics, Inc. has approximately 38 employees.